PACB

Pacific Biosciences of California, Inc.

PACB · CIK 1299130 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20182025
Net Income−$546M
20182025
Operating CF−$111M
20182025
Free Cash Flow−$114M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue———————$0.1B
Cost of Revenue$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.1B$0.1B
Gross Profit$0.0B$0.0B$0.1B$0.0B$0.1B$0.0B$0.0B$0.0B
R&D Expense$0.1B$0.1B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
SG&A Expense$0.1B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
Operating Income$-0.6B$-0.5B$-0.3B$-0.3B$-0.2B$-0.1B$-0.0B$-0.0B
Net Income$-0.5B$-0.3B$-0.3B$-0.3B$-0.2B$0.0B$-0.0B$-0.0B
EPS (Basic)$-1.82$-1.13$-1.21$-1.40$-0.89$0.18——
EPS (Diluted)$-1.82$-1.59$-1.21$-1.40$-0.89$0.17——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.8B$1.3B$1.7B$1.8B$2.0B$0.4B$0.1B$0.2B
Current Assets$0.4B$0.5B$0.7B$0.9B$1.1B$0.4B$0.1B$0.1B
Cash & Equivalents$0.1B$0.1B$0.2B$0.3B$0.5B$0.1B$0.0B$0.0B
Total Liabilities$0.8B$0.8B$1.0B$1.2B$1.2B$0.1B$0.1B$0.1B
Current Liabilities$0.1B$0.1B$0.1B$0.3B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.5B$0.7B$0.6B$0.8B$0.3B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.1B$-0.2B$-0.3B$-0.3B$-0.1B$0.0B$-0.1B$-0.1B
Investing Cash Flow$0.1B$0.1B$0.0B$0.1B$-0.7B$-0.2B$0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.0B$0.1B$0.0B$1.2B$0.3B$0.0B$0.1B
← Companies